Rapid Micro Biosystems (RPID) Enterprise Value (2020 - 2025)
Rapid Micro Biosystems (RPID) has disclosed Enterprise Value for 6 consecutive years, with -$18.4 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 63.8% to -$18.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.4 million through Dec 2025, up 63.8% year-over-year, with the annual reading at -$18.4 million for FY2025, 63.8% up from the prior year.
- Enterprise Value hit -$18.4 million in Q4 2025 for Rapid Micro Biosystems, up from -$22.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13.1 million in Q2 2025 to a low of -$221.0 million in Q3 2021.
- Historically, Enterprise Value has averaged -$73.1 million across 5 years, with a median of -$65.9 million in 2023.
- Biggest five-year swings in Enterprise Value: plummeted 605.05% in 2022 and later skyrocketed 81.09% in 2025.
- Year by year, Enterprise Value stood at -$15.4 million in 2021, then tumbled by 605.05% to -$108.6 million in 2022, then increased by 15.27% to -$92.1 million in 2023, then soared by 44.89% to -$50.7 million in 2024, then skyrocketed by 63.8% to -$18.4 million in 2025.
- Business Quant data shows Enterprise Value for RPID at -$18.4 million in Q4 2025, -$22.4 million in Q3 2025, and -$13.1 million in Q2 2025.